Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron and its subvariants (BA.2, BA.4, BA.5) represented the most commonly circulating variants of concern (VOC) in the coronavirus disease 2019 (COVID-19) pandemic in 2022. Despite high vaccination rates with approved SARS-CoV-2 vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Roth, Nicole, Gergen, Janina, Kovacikova, Kristina, Mueller, Stefan O., Ulrich, Lorenz, Schön, Jacob, Halwe, Nico Joel, Fricke, Charlie, Corleis, Björn, Dorhoi, Anca, Hoffmann, Donata, Beer, Martin, Maione, Domenico, Petsch, Benjamin, Rauch, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965737/
https://www.ncbi.nlm.nih.gov/pubmed/36851196
http://dx.doi.org/10.3390/vaccines11020318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965737/
https://www.ncbi.nlm.nih.gov/pubmed/36851196
http://dx.doi.org/10.3390/vaccines11020318

Ejemplares similares